Silk Road Medical, Inc
NASDAQ Global SelectTotal Valuation
Silk Road Medical, Inc carries a market capitalization of 1.12B, placing it among publicly traded companies globally. Its enterprise value stands at 967.22M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.12B |
| Enterprise Value | 967.22M |
Share Statistics
Silk Road Medical, Inc currently has 40.61M shares outstanding.
| Shares Outstanding | 40.61M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 5.54, and the price-to-book ratio stands at -2.47.
| PE Ratio | N/A |
| PS Ratio | 5.54 |
| PB Ratio | -2.47 |
| P/TBV Ratio | 6.86 |
| P/FCF Ratio | -33.34 |
| P/OCF Ratio | -31.26 |
Enterprise Valuation
| EV / Sales | 5.05 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Silk Road Medical, Inc maintains a current ratio of 7.63, meaning it holds 7.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 50.37, indicating elevated leverage, while an interest coverage ratio of -8.17 demonstrates limited ability to service its debt obligations.
| Current Ratio | 7.63 |
| Quick Ratio | 6.28 |
| Debt / Equity | 50.37 |
| Debt / EBITDA | -1.38 |
| Interest Coverage | -8.17 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -21.21 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.02 |
Stock Price Statistics
Silk Road Medical, Inc's stock has gained approximately 274.01361% over the past 52 weeks. The 50-day moving average sits at 27.10, while the 200-day moving average is 19.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | 274.01361% |
| 50-Day Moving Average | 27.10 |
| 200-Day Moving Average | 19.85 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Silk Road Medical, Inc generated 191.43M in revenue and converted that into -56.54M in net income, yielding earnings per share of -1.44. EBITDA reached -56.44M, while operating income came in at -60.17M.
| Revenue | 191.43M |
| Gross Profit | 142.19M |
| Operating Income | -60.17M |
| Pretax Income | -56.54M |
| Net Income | -56.54M |
| EBITDA | -56.44M |
| EBIT | -60.17M |
| Earnings Per Share (EPS) | -1.44 |
Balance Sheet
Silk Road Medical, Inc holds 171.98M in cash and equivalents against 77.91M in total debt, resulting in a net debt position of 53.51M. Total book value stands at -430.15M, with working capital of 209.45M providing operational flexibility.
| Cash & Cash Equivalents | 171.98M |
| Total Debt | 77.91M |
| Net Debt | 53.51M |
| Equity (Book Value) | -430.15M |
| Book Value Per Share | -10.96 |
| Working Capital | 209.45M |
Cash Flow
Silk Road Medical, Inc produced -33.96M in operating cash flow over the past twelve months. After subtracting -2.13M in capital expenditures, free cash flow totaled -36.08M - equivalent to -0.92 per share.
| Operating Cash Flow | -33.96M |
| Capital Expenditures | -2.13M |
| Free Cash Flow | -36.08M |
| FCF Per Share | -0.92 |
Margins
Silk Road Medical, Inc operates with a gross margin of 74.28, reflecting its pricing power and cost economics. The operating margin of -31.43 and net profit margin of -29.53 provide insight into operational efficiency.
| Gross Margin | 74.28 |
| Operating Margin | -31.43 |
| Pretax Margin | -29.53 |
| Profit Margin | -29.53 |
| EBITDA Margin | -29.48 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -1.34 |
| FCF Yield | -3.00 |
Scores
Silk Road Medical, Inc posts an Altman Z-Score of 4.20, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.20 |